RxDoctor Payments Data
★ My doctorsLook up a doctor →

Ramandeep Mand, MD

Interventional Cardiology · Mount Clemens, MINPI 1831621408

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,143 of the $6,857 with a category attached, or 75.0%. It is spread thinly across 29 manufacturers, the largest accounting for just 20.4%. That places this record below the midpoint for interventional cardiology clinicians in MI, where the typical reported total is $6,857.

$6,857in general payments, 2019–2025

Across 119 payments — averaging $57.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Amgen$1K
  • Abbott$606
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$605
  • Penumbra, Inc.$567
  • Inari Medical, Inc.$408
  • plus $2K from 23 others
$141in research payments, 2019–2025

Across 1 payment — averaging $140.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abiomed$141

What the payments were for

  • Grants$1,12616%
  • Food & beverage$5,14375%
  • Education$5889%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific6$1,402
Amgen19$1,095
Abbott10$606
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)11$605
Penumbra, Inc.4$567
Inari Medical, Inc.6$408
Shockwave Medical, Inc3$231
Novartis13$207
Kestra Medical Technology Services, Inc.3$189
AstraZeneca6$165
Johnson & Johnson3$157
Philips North America LLC2$141
ZOLL Circulation Inc2$130
Novo Nordisk1$122
Boehringer Ingelheim1$116
Cardiva Medical, Inc.3$114
Medtronic4$109
Abiomed3$99
Actelion Pharmaceuticals US, Inc.2$71
Pfizer3$58
Edwards Lifesciences1$49
Cordis US CORP.3$49
Lantheus Medical Imaging, Inc.2$42
Chiesi USA, Inc.2$39
Cardiovascular Systems Inc.2$27
Terumo Medical Corporation1$19
E.r. Squibb & Sons, L.L.C.1$16
Teleflex LLC1$13
Stryker1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,857 in reported general payments places this provider in the 50th percentile of 187 interventional cardiology providers in Michigan.

See all interventional cardiology providers in Michigan →

Medicare billing

Part B allowed, 2024
$25,608
Medicare patients
115
Services billed
284

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate15$109

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Mount Clemens

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →